DIA Biosimilars 2013

Articles Published in 2010

Covance Revenue Up 8% in ‘09, Plans for 10% Growth in ‘10

Thursday, January 28, 2010 02:55 PM

Covance reported fourth-quarter revenue growth of 11% to $507 million, largely due to the positive impact of foreign exchange.

More... »

Cenduit: Now with Patient Reminders

MDS Warns Shareholders Not to Expect Much from Early-Stage Sale

Thursday, January 28, 2010 08:07 AM

As MDS continues its efforts to sell the rest of its contract research division, the company is preparing investors for less-than-expected earnings from that sale.

More... »

CRF Health – eCOA Forum

PPD Sells Biomarker Business to Caprion

Wednesday, January 27, 2010 07:59 AM

PPD’s plan to refocus its contract research organization (CRO) business is one step closer to final with the recent sale of its biomarker services division, PPD Biomarker Discovery Sciences, to Montreal-based Caprion Proteomics.

More... »

Parexel Reports 33% Drop in Income, Ups Guidance

Tuesday, January 26, 2010 07:14 AM

Parexel’s second quarter net income fell 33% to $3.5 million, or $0.06 per diluted share, compared with the same quarter last year.

More... »

Accurate Clinical Research Adds Second Location

Monday, January 25, 2010 12:09 PM

Houston, Texas-based Accurate Clinical Research (ACR), a self-described clinical coordinating center, has added a second location on Nassau Bay in Houston, where their new partnering physician has both his clinical practice and research practice.

More... »

Quintiles Rebrands with ‘New Health’

Monday, January 25, 2010 09:05 AM

Quintiles launched a new brand identity this morning, focused on what the contract research organization (CRO) is calling “The New Health”—the rapidly changing world of biopharma.

More... »

Unimed CRO Retools Name, Management

Friday, January 22, 2010 12:25 PM

Unimed, a contract research organization (CRO) in Prague, announced a name change and new management, following the final integration of its operations throughout Central and Eastern Europe.  The newly branded CRO—EastHORN—will continue to offer phase I to phase IV clinical trial services throughout the CEE region but plans to expand its reach to other countries within the region and perhaps as far as China and Africa in the future. The company has offices in Prague and Warsaw, as well as newly established offices in Bulgaria and Romania.

More... »

Medpace Acquires European CRO, Has Big Plans for Growth

Thursday, January 21, 2010 06:04 PM

Cincinnati-based contract research organization (CRO) Medpace acquired European CRO Medical Consulting Dr. Schlichtiger for an undisclosed sum.

More... »

Charges Filed in Case of Fabricated Study Results

Thursday, January 21, 2010 07:15 AM

Charges were filed in the case of Scott Reuben, the U.S. anesthesiologist who allegedly fabricated clinical trial data for at least 21 published articles. Reuben, who wrote about pain management after surgery, was formerly chief of acute pain at Bay State Hospital in Springfield, Mass.

More... »

PPD Plans for Single-Digit Growth

Wednesday, January 20, 2010 09:57 AM

PPD expects limited revenue growth in 2010, according to the contract research organization’s (CRO’s) 2010 guidance announced last night.

More... »

`
CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs